Word: clonings
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...good an impression of David Letterman as you'll find outside Saturday Night Live. And this one is way outside. The Dave clone is Harald Schmidt, host of a German late-night talk show that runs four days a week on SAT 1, a channel seen not only in Germany but also in several other European countries from Switzerland to Slovakia. His references to the American talk-show host are sometimes obvious and self-conscious: in one recurring bit, a postman drops off letters and Schmidt greets him, "Oh, look, the letterman." More often he simply copies Letterman's style...
...July I had the opportunity to teach creative writing to a group of East European students at Pennsylvania's West Chester University. Their eight-week stay was funded by Soros, whom I'd never heard of. We ought to clone him. Imagine, a business tycoon who spends a third of his day "thinking... about... where the world is going"! This is behavior we normally attribute to poets and philosophers, people we pretend to take seriously but prefer to confine to the ivory towers of a university, where their radical social ideas will pose no threat to our selfish individualism. JENNIFER...
Microsoft has managed to co-opt nearly everything. Yet as I sit facing my friendly Macintosh PowerPC and my nondescript IBM clone equipped with Windows 95, I know that only one of these machines has a soul. Rob Parsons Sitka, Alaska...
Apple isn't listening, though: It plans to shut down Power Computing's operation by the end of the year, and is already targeting other clone-makers such as Motorola and UMAX by imposing higher licensing fees for the Mac Operating System. Why so hard on the clones? Acting chairman Steve Jobs, whose dislike of the clone licensing system set up in 1994 is no great secret, would probably describe the move as consolidation ? buying back a large share of the Mac market. But coming at a time when the Mac market itself is shrinking, today's move resembles nothing...
...week apart in the journals Science and Cell, two teams of researchers--one led by Nobel-prizewinning biochemist Thomas Cech of the University of Colorado, the other by M.I.T.'s Weinberg--have announced a breakthrough that could help bring about such a drug. Both teams have managed to clone a gene that controls the activity of the telomerase enzyme in human cells. That could set the stage for development not only of inhibiting drugs but also of substances that switch on the enzyme--which might help combat degenerative diseases associated with aging...